INTERNATIONAL PATENT: NOVMETAPHARMA CO., LTD., 주식회사 노브메타파마 FILES APPLICATION FOR "USE OF CYCLO-HISPRO ALONE OR ZINC AND CYCLO-HISPRO FOR INHIBITING MUSCLE LOSS OR ALLEVIATING MUSCLE FUNCTION DECLINE CAUSED BY ANTI-OBESITY DRUGS"

GENEVA, Nov. 11 -- NOVMETAPHARMA CO., LTD. (13th Floor, 727, Eonju-ro,Gangnam-gu,Seoul 06050), 주식회사 노브메타파마 (서울특별시강남구언주로 727, 13층) filed a patent application (PCT/KR2025/005931) for "USE OF CYCLO-HISPRO ALONE OR ZINC AND CYCLO-HISPRO FOR INHIBITING MUSCLE LOSS OR ALLEVIATING MUSCLE FUNCTION DECLINE CAUSED BY ANTI-OBESITY DRUGS" on Apr 30, 2025. With publication no. WO/2025/230339, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World...